Clinical trial
Multiparametric MRI for Assessing Breast Cancer Response to Anti-HER2 Therapy
NCT03738553
Study timeline
Study start (actual)2013-08-01Date precision: month
Registry last updated2026-05-04
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
HER2-positive Breast Cancerunresolved
Interventions
MRIDEVICE
TrastuzumabDRUG · verified · RxNorm: trastuzumab
Sponsors & collaborators
University of Washingtonlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03738553 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.